Alembic Ltd — Investor Relations & Filings
Alembic Ltd is a long-standing pharmaceutical enterprise focused on the development, manufacturing, and marketing of generic pharmaceutical products and active pharmaceutical ingredients (APIs). Established in 1907, the company operates through a vertically integrated model, covering the entire value chain from research and development to commercial distribution. Its product portfolio spans several therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, and respiratory treatments. The organization maintains advanced manufacturing facilities and dedicated research centers to support its global supply chain. Alembic serves diverse international markets, providing high-quality formulations and bulk drugs to healthcare providers and partners. The company is recognized for its expertise in fermentation technology and its commitment to meeting international regulatory standards for pharmaceutical production.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Copy of Newspaper Publication | 2026-04-17 | English | |
| Copy of Newspaper Publication | 2026-04-15 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | |
| Trading Window | 2026-03-27 | English | |
| Copy of Newspaper Publication | 2026-02-13 | English | |
| Outcome of Board Meeting | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 42205520 | Copy of Newspaper Publication | 2026-04-17 | English | ||
| 42172805 | Copy of Newspaper Publication | 2026-04-15 | English | ||
| 42204512 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | ||
| 42219965 | Trading Window | 2026-03-27 | English | ||
| 42245314 | Copy of Newspaper Publication | 2026-02-13 | English | ||
| 42178329 | Outcome of Board Meeting | 2026-02-12 | English | ||
| 42210245 | Copy of Newspaper Publication | 2026-02-11 | English | ||
| 43858439 | Board Meeting — Board Meeting Intimation | 2026-02-03 | English | ||
| 43858468 | Board Meeting — Financial Results/Other business matters | 2026-02-03 | English | ||
| 42231514 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-01-05 | English | ||
| 42204406 | Updates | 2026-01-01 | English | ||
|
2025
4 filings
| |||||
| 42250544 | Trading Window | 2025-12-26 | English | ||
| 42231020 | Copy of Newspaper Publication | 2025-12-15 | English | ||
| 42248750 | Copy of Newspaper Publication | 2025-11-28 | English | ||
| 42336405 | Copy of Newspaper Publication | 2025-11-11 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BridgeBio Oncology Therapeutics, Inc.
Clinical-stage biopharma developing inhibitors for genetica…
|
BBOT | US | Manufacturing |
|
BridgeBio Pharma, Inc.
Develops transformative medicines for genetic diseases and …
|
BBIO | US | Manufacturing |
|
Brightgene Bio-Medical Technology Co., Ltd.
Research-driven developer of complex APIs, high-end generic…
|
688166 | CN | Manufacturing |
|
BRIGHT MINDS BIOSCIENCES INC.
Develops selective serotonin agonists for neurological and …
|
DRUG | US | Manufacturing |
|
BrightPath Biotherapeutics Co., Ltd.
A clinical-stage biopharma company developing cancer immuno…
|
4594 | JP | Manufacturing |
|
Brii Biosciences Limited
Developing first-in-class therapies targeting infectious an…
|
2137 | KY | Manufacturing |
|
BRISTOL MYERS SQUIBB CO
A global biopharmaceutical company that discovers, develops…
|
BMY | US | Manufacturing |
|
BROOKS LABORATORIES LIMITED
Pharmaceutical manufacturer specializing in CRAMS and diver…
|
BROOKS | IN | Manufacturing |
|
BUKWANG PHARMACEUTICAL IND CO.,LTD
An R&D-focused company developing drugs for CNS disorders a…
|
003000 | KR | Manufacturing |
|
BY-HEALTH CO.,LTD
Researches, develops, and distributes dietary supplements, …
|
300146 | CN | Manufacturing |
Alembic Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61312/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61312 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61312 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61312 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61312}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alembic Ltd (id: 61312)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.